← Open Payments lookup

NICOLE MAKRAKIS: Open Payments

NPI 1033899794 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$842 in 19 payments from 5 companies in 2025. Trend: 2023 $30 · 2024 $182 · 2025 $842

Food & beverage: $842
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$508
Gilead Sciences, Inc.1$147
Madrigal Pharmaceuticals4$94
Ipsen Biopharmaceuticals, Inc4$79
Novo Nordisk Inc1$15

Products named: XIFAXAN, REZDIFFRA, IQIRVO, Wegovy.

Industry payments across TX — which companies pay providers there.